Clinical Trials Browser

OTHER × Hematologic Diseases × Azacitidine × Clear all

NCT07387354 2026-03-16

MDS

Phase 1/2 Not yet recruiting

Bone Marrow Diseases, Hematologic Diseases, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT04062266 2026-01-13

AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission

Phase 2 Active not recruiting

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Myeloid, Acute